Usman "Oz" Azam

Usman "Oz" Azam is the Chief Executive Officer of Inspirna, Inc., a biopharmaceutical company. He joined Inspirna as CEO in May 2023, bringing over two decades of drug development experience to the role.5

Professional Background

Azam is recognized as a world-class thought leader in the pharmaceutical industry, known for his clear and open communication style focused on delivering superior results.1 His extensive experience in drug development makes him a valuable asset to Inspirna's leadership team.

Career Highlights

• Inspirna, Inc.: Appointed as CEO in May 20235
• Tmunity: Joined in 2018, playing a significant role in the company's development3
• Previous Experience: Over 20 years in drug development across various companies

Expertise and Leadership

Azam's expertise spans several areas:

• Drug development
• Cell and gene therapy
• Industry leadership
• Strategic planning

He has been involved in presenting Inspirna's clinical data at major conferences, such as the European Society for Medical Oncology (ESMO) Congress.7 Azam also actively participates in industry discussions, having been invited to podcasts to share his insights on the cell and gene therapy field.4

Recent Achievements

Under Azam's leadership, Inspirna has made significant strides:

• Partnered with Merck KGaA, Darmstadt, Germany, to accelerate the global development of Ompenaclid (RGX-202)6
• Presented clinical data from Phase 1b/2 study of Ompenaclid in advanced colorectal cancer at ESMO7

Azam's role at Inspirna involves driving the company's growth, overseeing drug development programs, and representing the company at major industry events like the J.P. Morgan Healthcare Conference (JPM).2